Robert Martin, MD
Surgical Oncology · Louisville, KYNPI 1619947504
Payments from drug & device makers
Across 345 payments — averaging $5632.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$947K
- Merck$536K
- Varian Medical Systems, Inc.$75K
- ABK Biomedical USA, Inc.$67K
- Boston Scientific$62K
- Eisai Inc.$52K
- plus $204K from 26 others
Across 3 payments — averaging $35,086 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$100K
- Onquality Pharmaceuticals (USA) LLC$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 114 | $946,703 |
| Merck | 37 | $536,101 |
| Varian Medical Systems, Inc. | 2 | $75,064 |
| ABK Biomedical USA, Inc. | 19 | $67,319 |
| Boston Scientific | 5 | $61,834 |
| Eisai Inc. | 51 | $52,110 |
| Siemens Medical Solutions USA, Inc. | 2 | $50,130 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35,276 |
| Medical Device Business Services, Inc. | 22 | $34,352 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $33,298 |
| BK Medical Holding Company Inc. | 3 | $12,825 |
| Galil Medical Inc. | 8 | $12,665 |
| Biocompatibles, Inc. | 2 | $6,662 |
| Biocompatibles UK Ltd | 4 | $5,235 |
| Johnson & Johnson(2 entities) | 14 | $3,976 |
| AstraZeneca | 5 | $2,467 |
| Covidien LP | 1 | $2,375 |
| Healthmyne, Inc. | 2 | $1,847 |
| Sirtex Medical Inc | 1 | $1,750 |
| AbbVie | 16 | $329 |
| Medtronic | 3 | $294 |
| Galvanize Therapeutics, Inc | 1 | $214 |
| Abbott | 7 | $128 |
| KARL Storz Endoscopy-america | 1 | $77 |
| Novo Nordisk | 4 | $71 |
| Alcresta Therapeutics, Inc. | 2 | $70 |
| Astellas Pharma US Inc | 4 | $58 |
| Lexington Medical, Inc. | 1 | $47 |
| Bayer | 3 | $40 |
| Genentech, Inc. | 1 | $32 |
| Seagen Inc. | 1 | $16 |
| Acera Surgical, Inc. | 1 | $13 |
How this compares
$1,943,378 in reported general payments places this provider in the 95th percentile of 29 surgical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Louisville
- Nicolas AjkayLouisville$40K
- Charles ScogginsLouisville$15K
- Prejesh PhilipsLouisville$9K
- Michael EggerLouisville$3K
- Amy QuilloLouisville$908
- Alissa DollLouisville$439
- Kelly McMastersLouisville$438
- Neal BhutianiLouisville$398
- Allison HatmakerLouisville$148
- Michael EdwardsLouisville$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.